In: Annals of the New York Academy of Sciences Prez-Reytor D, Puebla C, Karahanian E, Garca K (2021) Use of short-chain fatty acids for the recovery of the intestinal epithelial barrier affected by bacterial toxins
For a deeper look at how people manage treatment tolerance, see our article on GLP-1s and side effects
Despite concerns about heart rate elevation, extensive cardiovascular outcome trials have demonstrated that GLP-1 receptor agonists are not only safe but may offer cardiovascular benefits for many patients
By The Numbers How Common Is GLP-1 Hair Loss
Clinical trials are exploring the prognostic utility of retinal biomarkers
One-third of those patients saw their weight fall into a healthy range, while two-thirds dropped below the threshold for obesity, according to The Wall Street Journal